HMG-1 as a late mediator of endotoxin lethality in mice - PubMed (original) (raw)
. 1999 Jul 9;285(5425):248-51.
doi: 10.1126/science.285.5425.248.
O Bloom, M Zhang, J M Vishnubhakat, M Ombrellino, J Che, A Frazier, H Yang, S Ivanova, L Borovikova, K R Manogue, E Faist, E Abraham, J Andersson, U Andersson, P E Molina, N N Abumrad, A Sama, K J Tracey
Affiliations
- PMID: 10398600
- DOI: 10.1126/science.285.5425.248
HMG-1 as a late mediator of endotoxin lethality in mice
H Wang et al. Science. 1999.
Abstract
Endotoxin, a constituent of Gram-negative bacteria, stimulates macrophages to release large quantities of tumor necrosis factor (TNF) and interleukin-1 (IL-1), which can precipitate tissue injury and lethal shock (endotoxemia). Antagonists of TNF and IL-1 have shown limited efficacy in clinical trials, possibly because these cytokines are early mediators in pathogenesis. Here a potential late mediator of lethality is identified and characterized in a mouse model. High mobility group-1 (HMG-1) protein was found to be released by cultured macrophages more than 8 hours after stimulation with endotoxin, TNF, or IL-1. Mice showed increased serum levels of HMG-1 from 8 to 32 hours after endotoxin exposure. Delayed administration of antibodies to HMG-1 attenuated endotoxin lethality in mice, and administration of HMG-1 itself was lethal. Septic patients who succumbed to infection had increased serum HMG-1 levels, suggesting that this protein warrants investigation as a therapeutic target.
Similar articles
- High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes.
Andersson U, Wang H, Palmblad K, Aveberger AC, Bloom O, Erlandsson-Harris H, Janson A, Kokkola R, Zhang M, Yang H, Tracey KJ. Andersson U, et al. J Exp Med. 2000 Aug 21;192(4):565-70. doi: 10.1084/jem.192.4.565. J Exp Med. 2000. PMID: 10952726 Free PMC article. - HMG-1 as a mediator of acute lung inflammation.
Abraham E, Arcaroli J, Carmody A, Wang H, Tracey KJ. Abraham E, et al. J Immunol. 2000 Sep 15;165(6):2950-4. doi: 10.4049/jimmunol.165.6.2950. J Immunol. 2000. PMID: 10975801 - HMG-1 rediscovered as a cytokine.
Yang H, Wang H, Tracey KJ. Yang H, et al. Shock. 2001 Apr;15(4):247-53. doi: 10.1097/00024382-200115040-00001. Shock. 2001. PMID: 11303722 Review. - PACAP inhibit the release and cytokine activity of HMGB1 and improve the survival during lethal endotoxemia.
Tang Y, Lv B, Wang H, Xiao X, Zuo X. Tang Y, et al. Int Immunopharmacol. 2008 Dec 10;8(12):1646-51. doi: 10.1016/j.intimp.2008.07.014. Epub 2008 Aug 17. Int Immunopharmacol. 2008. PMID: 18713653 - [The role of cytokines in endotoxic shock and in endotoxin hypersensitivity].
Freudenberg MA, Ness T, Kumazawa Y, Galanos C. Freudenberg MA, et al. Immun Infekt. 1993 Apr;21(2):40-4. Immun Infekt. 1993. PMID: 8340136 Review. German.
Cited by
- Curcumin and Vitamin D Reduce HMGB-1 mRNA Levels in Mice Infected with Salmonella typhi.
Febriza A, Idrus HH. Febriza A, et al. Malays J Med Sci. 2024 Oct;31(5):143-150. doi: 10.21315/mjms2024.31.5.10. Epub 2024 Oct 8. Malays J Med Sci. 2024. PMID: 39416736 Free PMC article. - Macrophages in the Context of Muscle Regeneration and Duchenne Muscular Dystrophy.
Hernandez-Torres F, Matias-Valiente L, Alzas-Gomez V, Aranega AE. Hernandez-Torres F, et al. Int J Mol Sci. 2024 Sep 27;25(19):10393. doi: 10.3390/ijms251910393. Int J Mol Sci. 2024. PMID: 39408722 Free PMC article. Review. - Genetic effect of basal metabolic rate on the benign neoplasm of bone and articular cartilage: a Mendelian randomization study.
Huang G, Yao Y, Fan L, Li S. Huang G, et al. Front Oncol. 2024 Sep 26;14:1446310. doi: 10.3389/fonc.2024.1446310. eCollection 2024. Front Oncol. 2024. PMID: 39391241 Free PMC article. - Lactate's impact on immune cells in sepsis: unraveling the complex interplay.
Zhang T, Chen L, Kueth G, Shao E, Wang X, Ha T, Williams DL, Li C, Fan M, Yang K. Zhang T, et al. Front Immunol. 2024 Sep 20;15:1483400. doi: 10.3389/fimmu.2024.1483400. eCollection 2024. Front Immunol. 2024. PMID: 39372401 Free PMC article. Review. - Overexpression of serum HMGB1 and IDO in esophageal squamous cell carcinoma patients: potential clinical auxiliary diagnostic markers and immunotherapeutic targets.
Cui W, Niu Y, Zhang X, Huang B, Shang X, Zhao W, Yan X, Mi Y, Ma M, Zhang J, Yang X. Cui W, et al. Front Oncol. 2024 Sep 9;14:1452282. doi: 10.3389/fonc.2024.1452282. eCollection 2024. Front Oncol. 2024. PMID: 39314628 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases